Hyperpolarized [2-13C] Pyruvate is one of 9 therapeutic programs targeting Traumatic Brain Injury. It is currently in Phase 1.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
9 competitors in Traumatic Brain Injury
Hyperbaric Oxygen Therapy
Bont-a
Precedex
Versed
Hyperpolarized Pyruvate
Hyperpolarized [1-13c] Pyruvate
Angiotensin-(1-7)
Hyperpolarized [2-13C] Pyruvate
Sterile Saline
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details